Nuclear Antigen Antikörper
-
- Target Alle Nuclear Antigen (IPO-38) Antikörper anzeigen
- Nuclear Antigen (IPO-38)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Nuclear Antigen Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), ELISA, Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Spezifität
- Reacts with human Proliferation Marker IPO-38. This antigen was detected after 12 h of PHA-induced activation in the early G1 phase but absent in non-stimulated lymphocytes.
- Aufreinigung
- Purified (protein A)
- Immunogen
- Spleen cells of a human patient with hairy cell leukemia.
- Klon
- Clon IPO-38
- Top Product
- Discover our top product IPO-38 Primärantikörper
-
anti-Nuclear Antigen (IPO-38) antibody
IPO-38 Reaktivität: Maus IHC, IP, ELISA, WB Wirt: Maus Monoclonal IPO-38 unconjugated
anti-Nuclear Antigen (IPO-38) antibodyIPO-38 Reaktivität: Human, Maus, Ratte FACS, IF, IHC, StM Wirt: Maus Monoclonal SPM260 unconjugated
anti-Nuclear Antigen (IPO-38) antibodyIPO-38 Reaktivität: Human, Maus, Ratte FACS, IF, IHC (p) Wirt: Maus Monoclonal IPO-38 unconjugated
-
- Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
ELISA (1:10000 - 1:50000) IHC - F, IHC - P (10 μg/mL) IP, WB (1:500 - 1:2000) - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.02 M potassium phosphate, 0.5 M NaCl, pH 7.2
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Long term: -20°C, Short term: -20°C
-
- Target
- Nuclear Antigen (IPO-38)
- Andere Bezeichnung
- Proliferation Marker IPO-38 (IPO-38 Produkte)
-
